Growth Metrics

Cellectis (CLLS) Other Gross PP&E Adjustments (2014 - 2026)

Cellectis (CLLS) posted Other Gross PP&E Adjustments of $16.9 million for Q1 2026, up 11.53% on a QoQ basis from $15.1 million in Q4 2025, and up 5.67% year-over-year from $16.0 million in Q1 2025.

Cellectis (CLLS) has 13 years of Other Gross PP&E Adjustments data on file, last reported at $16.9 million in Q1 2026.

  • In Q1 2026, Other Gross PP&E Adjustments rose 5.67% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (up 5.67% YoY), while the FY2025 annual figure was $15.1 million, down 5.0% from the prior year.
  • Other Gross PP&E Adjustments grew to $16.9 million in Q1 2026, from $15.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $59.2 million in Q4 2023 and bottomed at $12.6 million in Q3 2022.
  • A 5-year average of $18.9 million and a median of $16.3 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
  • Annual changes were most pronounced in 2022 — Other Gross PP&E Adjustments surged 137.05% — and 2024, when it plunged 73.1%.
  • Year by year, Other Gross PP&E Adjustments stood at $12.6 million in 2022, then surged by 368.17% to $59.2 million in 2023, then plunged by 73.1% to $15.9 million in 2024, then dropped by 5.0% to $15.1 million in 2025, then advanced by 11.53% to $16.9 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at $16.9 million (Q1 2026), $15.1 million (Q4 2025), and $15.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -60,691.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -892,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -189.30 Mn
10 Cellectis 20.83 Bn 20.62 Bn - 16.88 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.88 Mn
Mar 31, 2026 16.88 Mn
Dec 31, 2025 15.13 Mn
Dec 31, 2025 15.13 Mn
Sep 30, 2025 15.69 Mn
Sep 30, 2025 15.69 Mn
Jun 30, 2025 15.41 Mn
Jun 30, 2025 15.41 Mn
Mar 31, 2025 15.97 Mn
Mar 31, 2025 15.97 Mn
Dec 31, 2024 15.93 Mn
Dec 31, 2024 15.93 Mn
Sep 30, 2024 16.73 Mn
Sep 30, 2024 16.73 Mn
Jun 30, 2024 16.70 Mn
Jun 30, 2024 16.70 Mn
Mar 31, 2024 16.26 Mn
Mar 31, 2024 16.26 Mn
Dec 31, 2023 59.21 Mn
Dec 31, 2023 59.21 Mn
Sep 30, 2023 17.63 Mn
Sep 30, 2023 17.63 Mn
Jun 30, 2023 17.77 Mn
Jun 30, 2023 17.77 Mn
Mar 31, 2023 18.27 Mn
Mar 31, 2023 18.27 Mn
Sep 30, 2022 12.65 Mn
Sep 30, 2022 12.65 Mn
Jun 30, 2022 12.87 Mn
Jun 30, 2022 12.87 Mn
Sep 30, 2021 8.64 Mn
Sep 30, 2021 8.64 Mn
Jun 30, 2021 5.43 Mn
Jun 30, 2021 5.43 Mn
Dec 31, 2020 19.20 Mn
Dec 31, 2020 19.20 Mn
Sep 30, 2020 -242,000.00
Sep 30, 2020 -242,000.00
Jun 30, 2020 -11.02 Mn
Jun 30, 2020 -11.02 Mn
Mar 31, 2020 -11.00 Mn
Mar 31, 2020 -11.00 Mn
Dec 31, 2019 -4.08 Mn
Dec 31, 2019 -4.08 Mn
Sep 30, 2019 -29.63 Mn
Sep 30, 2019 -29.63 Mn
Jun 30, 2019 -35.56 Mn
Jun 30, 2019 -35.56 Mn
Mar 31, 2019 -27.10 Mn
Mar 31, 2019 -27.10 Mn
Dec 31, 2018 26.16 Mn
Dec 31, 2018 26.16 Mn
Sep 30, 2018 8.30 Mn
Sep 30, 2018 8.30 Mn
Jun 30, 2018 7.44 Mn
Jun 30, 2018 7.44 Mn
Mar 31, 2018 7.69 Mn
Mar 31, 2018 7.69 Mn
Dec 31, 2017 22.10 Mn
Dec 31, 2017 22.10 Mn
Sep 30, 2017 8.23 Mn
Sep 30, 2017 8.23 Mn
Jun 30, 2017 17.01 Mn
Jun 30, 2017 17.01 Mn
Mar 31, 2017 17.12 Mn
Mar 31, 2017 17.12 Mn
Dec 31, 2016 17.31 Mn
Dec 31, 2016 17.31 Mn
Sep 30, 2016 16.90 Mn
Sep 30, 2016 16.90 Mn
Jun 30, 2016 17.17 Mn
Jun 30, 2016 17.17 Mn
Mar 31, 2016 12.86 Mn
Mar 31, 2016 12.86 Mn
Dec 31, 2015 5.53 Mn
Dec 31, 2015 5.53 Mn
Sep 30, 2015 5.43 Mn
Sep 30, 2015 5.43 Mn
Jun 30, 2015 5.66 Mn
Jun 30, 2015 5.66 Mn
Dec 31, 2014 3.26 Mn
Dec 31, 2014 3.26 Mn